Current Therapeutic Uses of Adipose-Derived Stem and Regenerative Cells

Chapter
First Online:

Abstract

The discovery of stem cells was followed by the discovery of stem cells with the highest numbers in the fat layer, known as adipose-derived stem and progenitor cells. Adult stem cells are undifferentiated, long-lived cells that have the capacity to self-renew and give rise to a differentiated progeny. The author discusses the therapeutic uses of autologous fat and stem cell transfer, the surgical steps of lipotransfer, stem cell use in natural breast augmentation, the therapeutic uses of stem cells, stem cell use in orthopedic surgery, stem cell use in wound healing, stem cells in cardiovascular disease, and FDA recommendations and guidelines.

Keywords

Stem Cell Vascular Endothelial Growth Factor Stem Cell Therapy Human Dermal Fibroblast Stromal Vascular Fraction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multi-lineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211–28.PubMedCrossRefGoogle Scholar
  2. 2.
    Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH. Human adipose tissue is a source of multi-potent stem cells. Mol Biol Cell. 2002;13(12):4279–95.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Panetta N, Gupta D, Kwan M, Wan DC, Commons GW, Longaker MT. Tissue harvest by means of suction-assisted or third-generation ultrasound-assisted lipoaspiration has no effect on osteogenic potential of human adipose-derived stromal cells. Plast Reconstr Surg. 2009;124(1):65–73.PubMedCrossRefGoogle Scholar
  4. 4.
    Yoshimura K, Sato K, Aoi N, Kurita M, Hirohi T, Harii K. Cell-assisted lipotransfer for cosmetic breast augmentation supportive use of adipose-derived stem/stromal cells. Aesthetic Plast Surg. 2008;32(1):48–55.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Coleman SR. Facial recontouring with lipostructure. Clin Plast Surg. 1997;24(2):347–67.PubMedGoogle Scholar
  6. 6.
    Guerrerosantos J, Haidar F, Paillet JC. Aesthetic facial contour augmentation with microlipofilling. Aesthet Surg J. 2003;23(4):239–47.PubMedCrossRefGoogle Scholar
  7. 7.
    Serra-Renom JM, Fontdevila J. Treatment of facial fat atrophy related to treatment with protease inhibitors by autologous fat injection in patients with human immunodeficiency virus infection. Plast Reconstr Surg. 2004;114(2):551–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg. 2007;119(3):775–85.PubMedCrossRefGoogle Scholar
  9. 9.
    Spear SL, Newman MK. Fat grafting to the breast revisited: safety and efficacy. Plast Reconstr Surg. 2007;119(3):786–7 (Discussion).CrossRefGoogle Scholar
  10. 10.
    Illouz YG, Sterodimas A. Autologous fat transplantation to the breast: a personal technique with 25 years of experience. Aesthetic Plast Surg. 2009;33(5):706–15.PubMedCrossRefGoogle Scholar
  11. 11.
    Ueberreiter K, et al. BEAULI™– a new and easy method for large-volume fat grafts. Handchir Mikrochir. 2010;42(6):379–85.CrossRefGoogle Scholar
  12. 12.
    Spear SL, Wilson HB, Lockwood MD. Fat injection to correct contour deformities in the reconstructed breast. Plast Reconstr Surg. 2005;116(5):1300–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Coleman SR. Hand rejuvenation with structural fat grafting. Plast Reconstr Surg. 2002;110(7):1731–44.PubMedCrossRefGoogle Scholar
  14. 14.
    Butterwick KJ. Lipoaugmentation for aging hands: a comparison of the longevity and aesthetic results of centrifuged versus noncentrifuged fat. Dermatol Surg. 2002;28(11):987–91.PubMedGoogle Scholar
  15. 15.
    Cárdenas-Camarena L, Arenas-Quintana R, Robles-Cervantes JA. Buttocks fat grafting: 14 years of evolution and experience. Plast Reconstr Surg. 2011;128(2):545–55.PubMedCrossRefGoogle Scholar
  16. 16.
    Roberts 3rd TL, Toledo LS, Badin AZ. Augmentation of the buttocks by micro fat grafting. Aesthet Surg J. 2001;21(4):311–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Cardenas Restrepo JC, Muñoz Ahmed JA. Large-volume lipoinjection for gluteal augmentation. Aesthet Surg J. 2002;22(1):33–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Veber Jr M, Mojallal A. Calf augmentation with autologous tissue injection. Plast Reconstr Surg. 2010;125(1):423–4; author reply 424–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Mojallal A, Veber M, Shipkov C, Ghetu N, Foyatier JL, Braye F. Analysis of a series of autologous fat tissue transfer for lower limb atrophies. Ann Plast Surg. 2008;61(5):537–43.PubMedCrossRefGoogle Scholar
  20. 20.
    Erol OO, Gürlek A, Agaoglu G. Calf augmentation with autologous tissue injection. Plast Reconstr Surg. 2008;121(6):2127–33.PubMedCrossRefGoogle Scholar
  21. 21.
    American Society of Plastic Surgeons (ASPS) website, Policy statements, 2012.Google Scholar
  22. 22.
    Rubin JP, Coon D, Zuley M, Toy J, Asano Y, Kurita M, Aoi N, Harii K, Yoshimura K. Mammographic changes after fat transfer to the breast compared with changes after breast reduction: a blinded study. Plast Reconstr Surg. 2012;129(5):1029–38.PubMedCrossRefGoogle Scholar
  23. 23.
    Kitamura K, Mori M, Sugimachi K. Stem cell augmented reconstruction: a new hope for reconstruction after breast conservative therapy, 2007. 30th annual San Antonio breast cancer symposium (poster presentation), San Antonio, 13–17 Dec 2007.Google Scholar
  24. 24.
    Pérez-Cano R, Vranckx JJ, Lasso JM, Calabrese C, Merck B, Milstein AM, Sassoon E, Delay E, Weiler-Mithoff EM. Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. Eur J Surg Oncol. 2012;38(5):382–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Moscatello DK, Dougherty M, Narins RS, Lawrence N. Cryopreservation of human fat for soft tissue augmentation: viability requires use of cryoprotectant and controlled freezing and storage. Dermatol Surg. 2005;31(11 Pt 2):1506–10.PubMedCrossRefGoogle Scholar
  26. 26.
    Fraser J, Wulur I, Alfonso Z, Hedrick M. Fat tissue: an underappreciated source of stem cells for biotechnology. Trends Biotechnol. 2006;24(4):150–4.PubMedCrossRefGoogle Scholar
  27. 27.
    American Society of Aesthetic Plastic Surgery (ASAPS) website, policy statement on stem cells, 2012Google Scholar
  28. 28.
    Eto H, Suga H, Aoi N, Kato H, Araki J, Doi K, Higashino T, Yoshimura K. Adipose injury-associated factors activate adipose stem/stromal cells, induce neo-angiogenesis, and mitigate hypoxia in ischemic tissues. Am J Pathol. 2013;178(5):2322–32.CrossRefGoogle Scholar
  29. 29.
    Eto H, Suga H, Matsumoto D, Inoue K, Aoi N, Kato H, Araki J, Yoshimura K. Characterization of adipose tissue structure and cellular components: differences between aspirated adipose tissue and excised adipose tissue. Plast Reconstr Surg. 2009;124(4):1087–97.PubMedCrossRefGoogle Scholar
  30. 30.
    Fan Y, Bergmann A. Apoptosis-induced compensatory proliferation. The cell is dead. Long live the cell! Trends Cell Biol. 2008;18(10):467–73.PubMedCrossRefPubMedCentralGoogle Scholar
  31. 31.
    Arca T, Proffitt J, Genever P. Generating 3D tissue constructs with mesenchymal stem cells and a cancellous bone graft for orthopaedic applications. Biomed Mater. 2011;6(2):025006.PubMedCrossRefGoogle Scholar
  32. 32.
    Shoji T, Ii M, Mifune Y, Matsumoto T, Kawamoto A, Kwon SM, Kuroda T, Kuroda R, Kurosaka M, Asahara T. Local transplantation of human multipotent adipose-derived stem cells accelerates fracture healing via enhanced osteogenesis and angiogenesis. Lab Invest. 2010;90(4):637–49.PubMedCrossRefGoogle Scholar
  33. 33.
    Atesok K, Li R, Stewart DJ, Schemitsch EH. Endothelial progenitor cells promote fracture healing in a segmental bone defect model. J Orthop Res. 2010;28(8):1007–14.PubMedGoogle Scholar
  34. 34.
    Li R, Atesok K, Nauth A, Wright D, Qamirani E, Whyne CM, Schemitsch EH. Endothelial progenitor cells for fracture healing: a microcomputed tomography and biomechanical analysis. J Orthop Trauma. 2011;25(8):467–71.PubMedCrossRefGoogle Scholar
  35. 35.
    Kim WS, Park BS, Sung JH, Yang JM, Park SB, Kwak SJ, Park JS. Wound healing effect of adipose-derived stem cells: a critical role of secretory factors on human dermal fibroblasts. J Dermatol Sci. 2007;48(1):15–24.PubMedCrossRefGoogle Scholar
  36. 36.
    Blanton MW, Hadad I, Johnstone BH, Mund JA, Rogers PI, Eppley BL, March KL. Adipose stromal cells and platelet-rich plasma therapies synergistically increase revascularization during wound healing. Plast Reconstr Surg. 2009;123(2 Suppl):56S–64.PubMedCrossRefGoogle Scholar
  37. 37.
    Lee EY, Xia Y, Kim WS, Kim MH, Kim TH, Kim KJ, Park BS, Sung JH. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen. 2009;17(4):540–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167(10):989–97.PubMedCrossRefGoogle Scholar
  39. 39.
    Kang S, Yang YJ, Li CJ, Gao RL. Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and meta-analysis for randomized controlled trials. Coron Artery Dis. 2008;19(5):327–35.PubMedCrossRefGoogle Scholar
  40. 40.
    Anversa P, Kajstura J, Rota M, Leri A. Regenerating new heart with stem cells. J Clin Invest. 2013;123(1):62–70.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Rubart M, Field LJ. Cardiac regeneration: repopulating the heart. Annu Rev Physiol. 2006;68:29–49.PubMedCrossRefGoogle Scholar
  42. 42.
    Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisén J. Evidence for cardiomyocyte renewal in humans. Science. 2009;324(5923):98–102.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Laflamme MA, Murry CE. Heart regeneration. Nature. 2011;473(7347):326–35.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Vunjak-Novakovic G, Lui KO, Tandon N, Chien KR. Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng. 2011;13:245–67.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Xu H, Yi BA, Chien KR. Shortcuts to making cardiomyocytes. Nat Cell Biol. 2011;13(3):191–3.PubMedCrossRefGoogle Scholar
  46. 46.
    Kajstura J, Leti A, Finato N, Di Loreto C, Beltrami CA, Anversa P. Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A. 1998;95(15):8801–5.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Beltrami AP, Urbanek K, Kajstura J, Yan SM, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami CA, Anversa P. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med. 2001;344(23):1750–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Chimerism of the transplanted heart. N Engl J Med. 2002;346(1):5–15.PubMedCrossRefGoogle Scholar
  49. 49.
    Urbanek K, Quaini F, Tasca G, Torella D, Castaldo C, Nadal-Ginard B, Leri A, Kajstura J, Quaini E, Anversa P. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy. Proc Natl Acad Sci U S A. 2003;100(18):10440–5.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Urbanek K, Torella D, Sheikh F, De Angelis A, Nurzynska D, Silvestri F, Beltrami CA, Bussani R, Beltrami AP, Quaini F, Bolli R, Leri A, Kajstura J, Anversa P. Myocardial regeneration by activation of multi potent cardiac stem cells in ischemic heart failure. Proc Natl Acad Sci U S A. 2005;102(24):8692–7.PubMedCrossRefPubMedCentralGoogle Scholar
  51. 51.
    Kajstura J, Urbanek K, Perl S, Hosoda T, Zheng H, Ogórek B, Ferreira-Martins J, Goichberg P, Rondon-Clavo C, Sanada F, D’Amario D, Rota M, Del Monte F, Orlic D, Tisdale J, Leri A, Anversa P. Cardiomyogenesis in the adult human heart. Circ Res. 2010;107(2):305–15.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Kajstura J, Gurusamy N, Ogórek B, Goichberg P, Clavo-Rondon C, Hosoda T, D’Amario D, Bardelli S, Beltrami AP, Cesselli D, Bussani R, del Monte F, Quaini F, Rota M, Beltrami CA, Buchholz BA, Leri A, Anversa P. Myocyte turnover in the aging human heart. Circ Res. 2010;107(11):1374–86.PubMedCrossRefGoogle Scholar
  53. 53.
    Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P. Apoptosis in the failing human heart. N Engl J Med. 1997;336(16):1131–41.PubMedCrossRefGoogle Scholar
  54. 54.
    Engel FB, Schebesta M, Duong MT, Lu G, Ren S, Madwed JB, Jiang H, Wang Y, Keating MT. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes. Genes Dev. 2005;19(10):1175–87.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Kuhn B, del Monte F, Hajjar RJ, Chang YS, Lebeche D, Arab S, Keating MT. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13(8):962–9.PubMedCrossRefGoogle Scholar
  56. 56.
    Berseli K, Arab S, Haring B, Kühn B. Neuregulin l/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell. 2009;138(2):257–70.CrossRefGoogle Scholar
  57. 57.
    Kubin T, Pöling J, Kostin S, Gajawada P, Hein S, Rees W, Wietelmann A, Tanaka M, Lörchner H, Schimanski S, Szibor M, Warnecke H, Braun T. Oncostatin M is a major mediator of cardiomyocyte dedifferentiation and remodeling. Cell Stem Cell. 2011;9(5):420–32.PubMedCrossRefGoogle Scholar
  58. 58.
    Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell. 2003;114(6):763–76.PubMedCrossRefGoogle Scholar
  59. 59.
    Bearzi C, Leri A, Lo Monaco F, Rota M, Gonzalez A, Hosoda T, Pepe M, Qanud K, Ojaimi C, Bardelli S, D’Amario D, D’Alessandro DA, Michler RE, Dimmeler S, Zeiher AM, Urbanek K, Hintze TH, Kajstura J, Anversa P. Identification of a coronary vascular progenitor cell in the human heart. Proc Natl Acad Sci U S A. 2009;106(37):15885–90.PubMedCrossRefPubMedCentralGoogle Scholar
  60. 60.
    Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD. Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A. 2003;100(21):12313–8.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Bu L, Jiang X, Martin-Puig S, Caron L, Zhu S, Shao Y, Roberts DJ, Huang PL, Domian IJ, Chien KR. Human ISL1 heart progenitors generate diverse multipotent cardiovascular cell lineages. Nature. 2009;460(7251):113–7.PubMedCrossRefGoogle Scholar
  62. 62.
    Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I, Heffernan C, Menon MK, Scarlett CJ, Rashidianfar A, Biben C, Zoellner H, Colvin EK, Pimanda JE, Biankin AV, Zhou B, Pu WT, Prall OW, Harvey RP. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell. 2011;9(6):527–40.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Rota M, Kajstura J, Hosoda T, Bearzi C, Vitale S, Esposito G, Iaffaldano G, Padin-Iruegas ME, Gonzalez A, Rizzi R, Small N, Muraski J, Alvarez R, Chen X, Urbanek K, Bolli R, Houser SR, Leri A, Sussman MA, Anversa P. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci U S A. 2007;104(45):17783–8.PubMedCrossRefPubMedCentralGoogle Scholar
  64. 64.
    Kajstura J, Rota M, Whang B, Cascapera S, Hosoda T, Bearzi C, Nurzynska D, Kasahara H, Zias E, Bonafé M, Nadal-Ginard B, Torella D, Nascimbene A, Quaini F, Urbanek K, Leri A, Anversa P. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res. 2005;96(1):127–37.PubMedCrossRefGoogle Scholar
  65. 65.
    Steinhauser ML, Lee RT. Regeneration of the heart. EMBO Mol Med. 2011;3(12):701–12.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell. 2011;8(4):389–98.PubMedCrossRefGoogle Scholar
  67. 67.
    Lunde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, Endresen K, Ilebekk A, Mangschau A, Fjeld JG, Smith HJ, Taraldsrud E, Grøgaard HK, Bjørnerheim R, Brekke M, Müller C, Hopp E, Ragnarsson A, Brinchmann JE, Forfang K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355(12):1199–209.PubMedCrossRefGoogle Scholar
  68. 68.
    Meyer GP, Wollert KC, Lotz J, Steffens J, Lippolt P, Fichtner S, Hecker H, Schaefer A, Arseniev L, Hertenstein B, Ganser A, Drexler H. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation. 2006;113(10):1287–94.PubMedCrossRefGoogle Scholar
  69. 69.
    Beitnes JO, Hopp E, Lunde K, Solheim S, Arnesen H, Brinchmann JE, Forfang K, Aakhus S. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart. 2009;95(24):1983–9.PubMedCrossRefGoogle Scholar
  70. 70.
    Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD, Cardiovascular Cell Therapy Research Network. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA. 2011;306(19):2110–9.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Hatzopoulos AK, Gee AP, Taylor DA, Cogle CR, Smith D, Westbrook L, Chen J, Handberg E, Olson RE, Geither C, Bowman S, Francescon J, Baraniuk S, Piller LB, Simpson LM, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD, Cardiovascular Cell Therapy Research Network (CCTRN). Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUSCCTRN trial. JAMA. 2012;307(16):1717–26.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    D’Amario D, Cabral-Da-Silva MC, Zheng H, Fiorini C, Goichberg P, Steadman E, Ferreira-Martins J, Sanada F, Piccoli M, Cappetta D, D’Alessandro DA, Michler RE, Hosoda T, Anastasia L, Rota M, Leri A, Anversa P, Kajstura J. Insulin-like growth factor- 1 receptor identifies a pool of human cardiac stem cells with superior therapeutic potential for myocardial regeneration. Circ Res. 2011;108(12):1467–81.PubMedCrossRefPubMedCentralGoogle Scholar
  73. 73.
    Gonzalez A, Rota M, Nurzynska D, Misao Y, Tillmanns J, Ojaimi C, Padin-Iruegas ME, Müller P, Esposito G, Bearzi C, Vitale S, Dawn B, Sanganalmath SK, Baker M, Hintze TH, Bolli R, Urbanek K, Hosoda T, Anversa P, Kajstura J, Leri A. Activation of cardiac progenitor cells reverses the failing heart senescent phenotype and prolongs lifespan. Circ Res. 2008;102(5):597–606.PubMedCrossRefGoogle Scholar
  74. 74.
    Torella D, Rota M, Nurzynska D, Musso E, Monsen A, Shiraishi I, Zias E, Walsh K, Rosenzweig A, Sussman MA, Urbanek K, Nadal-Ginard B, Kajstura J, Anversa P, Leri A. Cardiac stem cell and myocyte aging, heart failure, and insulin-like growth factor- 1 overexpression. Circ Res. 2004;94(4):514–24.PubMedCrossRefGoogle Scholar
  75. 75.
    Ziebart T, Yoon CH, Trepels T, Wietelmann A, Braun T, Kiessling F, Stein S, Grez M, Ihling C, Muhly-Reinholz M, Carmona G, Urbich C, Zeiher AM, Dimmeler S. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res. 2008;103(11):1327–34.PubMedCrossRefGoogle Scholar
  76. 76.
    Valina C, Pinkernell K, Song YH, Bai X, Sadat S, Campeau RJ, Le Jemtel TH, Alt E. Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodeling after acute myocardial infarction. Eur Heart J. 2007;28(21):2667–77.PubMedCrossRefGoogle Scholar
  77. 77.
    Meliga E, Strem BM, Duckers HJ, Serruys PW. Adipose-derived cells. Cell Transplant. 2007;16(9): 963–70.PubMedCrossRefGoogle Scholar
  78. 78.
    Madonna R, Geng YJ, De Caterina R. Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arterioscler Thromb Vasc Biol. 2009;29(11):1723–9.PubMedCrossRefGoogle Scholar
  79. 79.
    Fraser J, Schreiber R, Strem B, Zhu M, Alfonso Z, Wulur I, Hedrick MH. Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes. Nat Clin Pract Cardiovasc Med. 2006;3 Suppl 1:S33–7.PubMedCrossRefGoogle Scholar
  80. 80.
    Houtgraaf J, den Dekker W, van Dalen B, Springeling T, de Jong R, van Geuns RJ, Geleijnse ML, Fernandez-Aviles F, Zijlsta F, Serruys PW, Duckers HJ. First experience in humans using adipose tissue–derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2012;59(5):539–40.PubMedCrossRefGoogle Scholar
  81. 81.
    Miranville A, Heeschen C, Sengenes C, Curat CA, Busse R, Bouloumié A. Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation. 2004;110(3):349–55.PubMedCrossRefGoogle Scholar
  82. 82.
    Planat-Benard V, Silvestre JS, Cousin B, André M, Nibbelink M, Tamarat R, Clergue M, Manneville C, Saillan-Barreau C, Duriez M, Tedgui A, Levy B, Pénicaud L, Casteilla L. Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation. 2004;109(5):656–63.PubMedCrossRefGoogle Scholar
  83. 83.
    Rehman J, Traktuev D, Li J, Merfeld-Clauss S, Temm-Grove CJ, Bovenkerk JE, Pell CL, Johnstone BH, Considine RV, March KL. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109(10):1292–8.PubMedCrossRefGoogle Scholar
  84. 84.
    Kondo K, Shintani S, Shibata R, Murakami H, Murakami R, Imaizumi M, Kitagawa Y, Murohara T. Implantation of adipose-derived regenerative cells enhances ischemia-induced angiogenesis. Arterioscler Thromb Vasc Biol. 2009;29(1):61–6.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.The Institute of Advanced Body SculptingLas VegasUSA

Personalised recommendations